Physician profile
Amanda B Rostkowski
NPI 1326365057
$735.55
in general payments reported to CMS, 2019-2025
20 companies · $86.87 in 2025
The $86.87 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $64.73 · 2021: $66.76 · 2022: $94.69 · 2023: $66.51 · 2024: $72.20 · 2025: $86.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.58 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $112.57 | 2019 | |
| Boston Scientific Corporation | $101.55 | 2019 | |
| Applied Medical Resources Corporation | $72.20 | 2024 | Gelpoint V-Path |
| Coopersurgical, INC. | $68.72 | 2019-2025 | Summit Doppler, Paragard T 380a |
| Abbvie INC. | $63.40 | 2020-2022 | |
| Exeltis, USA INC. | $56.16 | 2019-2022 | |
| Therapeuticsmd, INC. | $42.26 | 2019-2020 | |
| Pfizer INC. | $41.45 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.83 | 2020 | |
| Ethicon US, LLC | $20.98 | 2023 | Evarrest |
| Astellas Pharma US INC | $20.53 | 2023 | Veozah |
| Hologic Sales and Service, LLC | $19.62 | 2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $17.61 | 2021 | |
| Exact Sciences Corporation | $17.34 | 2025 | The Cologuard Plus Collection Kit |
| Aspira Women'S Health INC | $15.96 | 2025 | Ova1 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.20 | 2021 | |
| Minerva Surgical, INC | $14.36 | 2025 | |
| Avion Pharmaceuticals | $10.81 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Rostkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.